THRY (Thryv Holdings, Inc. Common Stock) Stock Analysis - Community

Thryv Holdings, Inc. Common Stock (THRY) is a publicly traded Communication Services sector company. As of May 21, 2026, THRY trades at $3.76 with a market cap of $151.68M and a P/E ratio of 373.50. THRY moved +0.00% today. Year to date, THRY is -34.94%; over the trailing twelve months it is -73.57%. Its 52-week range spans $1.91 to $20.92. Analyst consensus is buy with an average price target of $4.75. Rallies surfaces THRY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade THRY?

Rallies community data for THRY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

THRY Key Metrics

Key financial metrics for THRY
MetricValue
Price$3.76
Market Cap$151.68M
P/E Ratio373.50
EPS$0.01
Dividend Yield0.00%
52-Week High$20.92
52-Week Low$1.91
Volume7.39K
Avg Volume0
Revenue (TTM)$785.01M
Net Income$307.00K
Gross Margin67.86%

Latest THRY News

Recent THRY Insider Trades

  • Orfanos Lou bought 5.00K (~$13.00K) on Mar 18, 2026.
  • Slater John bought 2.00K (~$5.32K) on Mar 17, 2026.
  • Walsh Joe bought 15.00K (~$43.65K) on Mar 13, 2026.

THRY Analyst Consensus

5 analysts cover THRY: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.75.

Common questions about THRY

How does the Rallies community trade THRY?
Rallies community data for THRY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for THRY?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for THRY when enough community data is available.
Is THRY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for THRY. It does not provide personalized investment advice.
THRY

THRY